Detection of OXA-48 carbapenemase in the pandemic clone Escherichia coli O25b:H4-ST131 in the course of investigation of an outbreak of OXA-48-producing Klebsiella pneumoniae

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 7, 2012, Pages 4030-4031

  Morris, Dearbháile ^a   McGarry, Edel ^a   Cotter, Meaghan ^b   Passet, Virginie ^c   Lynch, Maureen ^b   Ludden, Catherine ^a   Hannan, Margaret M ^b   Brisse, Sylvain ^c   Cormican, Martin ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^c INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CARBAPENEMASE; CEFOTAXIME; CEFOXITIN; CEFPODOXIME; CEFTAZIDIME; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; KANAMYCIN; MEROPENEM; OXA 48 CARBAPENEMASE; PIPERACILLIN PLUS TAZOBACTAM; STREPTOMYCIN; UNCLASSIFIED DRUG;

AGED; ANTIBIOTIC SENSITIVITY; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CASE REPORT; CLONE; ENTEROBACTERIACEAE; EPIDEMIC; ESCHERICHIA COLI; HUMAN; KLEBSIELLA PNEUMONIAE; LETTER; LOWER RESPIRATORY TRACT INFECTION; MALE; MEDICAL DEVICE; MINIMUM INHIBITORY CONCENTRATION; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PANDEMIC; PNEUMONIA; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; SOFT TISSUE INFECTION;

AGED, 80 AND OVER; BETA-LACTAMASES; ESCHERICHIA COLI; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE;

EID: 84862577057     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00638-12     Document Type: Letter

References (18)

1. Barton B, Harding G, Zuccarelli A. 1995. A general method for detecting and sizing large plasmids. Anal. Biochem. 226:235-240.
2. Bush K. 2010. Alarming beta-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr. Opin. Microbiol. 13:558-564.
3. Carrer A, et al. 2010. Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob. Agents Chemother. 54:1369-1373.
4. Clermont O, et al. 2009. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 64:274-277.
5. Clinical and Laboratory Standards Institute. 2011. Performance standards for antimicrobial disk susceptibility tests; 21st informational supplement. Approved standard M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
6. Diancourt L, Passet V, Verhoef J, Grimont PA, Brisse S. 2005. Multilocus sequence typing of Klebsiella pneumoniae nosocomial isolates. J. Clin. Microbiol. 43:4178-4182.
7. Essack SY, Hall LM, Pillay DG, McFadyen ML, Livermore DM. 2001. Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum β-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa. Antimicrob. Agents Chemother. 45:88-95.
8. Mantengoli E, et al. 2011. Escherichia coli ST131 producing extended-spectrum beta-lactamases plus VIM-1 carbapenemase: further narrowing of treatment options. Clin. Infect. Dis. 52:690-691.
9. Masterton RG, et al. 2008. Guidelines for the management of hospital-acquired pneumonia in the UK: report of the Working Party on Hospital-Acquired Pneumonia of the British Society for Antimicrobial Chemotherapy. J. Antimicrob. Chemother. 62:5-34.
10. Morris D, et al. 2011. Production of KPC-2 carbapenemase by an Escherichia coli clinical isolate belonging to the international ST131 clone. Antimicrob. Agents Chemother. 55:4935-4936.
11. Naas T, Cuzon G, Gaillot O, Courcol R, Nordmann P. 2011. When carbapenem-hydrolyzing β-lactamase KPC meets Escherichia coli ST131 in France. Antimicrob. Agents Chemother. 55:4933-4934.
12. O'Brien DJ, et al. 2011. First isolation and outbreak of OXA-48-producing Klebsiella pneumoniae in an Irish hospital, March to June 2011. Euro Surveill. 16:pii=19921.
13. Peirano G, Schreckenberger PC, Pitout JD. 2011. The characteristics of NDM-1-producing Escherichia coli that belong to the successful and virulent clone ST131. Antimicrob. Agents Chemother. 55:2986-2988.
14. Rogers BA, Sidjabat HE, Paterson DL. 2011. Escherichia coli O25b-ST131: a pandemic, multi-resistant, community-associated strain. J. Antimicrob. Chemother. 66:1-14.
15. Swaminathan B, Barrett TJ, Hunter SB, Tauxe RV. 2001. PulseNet: the molecular subtyping network for foodborne bacterial disease surveillance, United States. Emerg. Infect. Dis. 7:382-389.
16. Walsh TR. 2010. Emerging carbapenemases: a global perspective. Int. J. Antimicrob. Agents 36(Suppl 3):S8-S14.
17. Woodford N, Fagan EJ, Ellington MJ. 2006. Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamases. J. Antimicrob. Chemother. 57:154-155.
18. Woodford N, et al. 2004. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β-lactamase, KPC-3, in a New York medical center. Antimicrob. Agents Chemother. 48:4793-4799.